Success Metrics

Clinical Success Rate
60.0%

Based on 3 completed trials

Completion Rate
60%(3/5)
Active Trials
1(11%)
Results Posted
33%(1 trials)
Terminated
2(22%)

Phase Distribution

Ph not_applicable
6
67%
Ph phase_3
1
11%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 3Large-scale testing
1(14.3%)
N/ANon-phased studies
6(85.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(2)
Completed(3)
Terminated(2)
Other(2)

Detailed Status

Completed3
unknown2
Terminated2
Not yet recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
60.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (14.3%)
N/A6 (85.7%)

Trials by Status

unknown222%
not_yet_recruiting111%
terminated222%
completed333%
active_not_recruiting111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
OTHER
Total Trials
9